PAVmed Inc. Series Z Warrant
PAVMZ
PAVMZ was delisted on the 30th of April, 2025.
9 hedge funds and large institutions have $2.06M invested in PAVmed Inc. Series Z Warrant in 2021 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 0 closing their positions.
286% more capital invested
Capital invested by funds: $533K → $2.06M (+$1.53M)
50% more funds holding
Funds holding: 6 → 9 (+3)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
+$784K |
| 2 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$314K |
| 3 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
+$26.7K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$3.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LCS
Levin Capital Strategies
New York
|
-$578K |
| 2 |
TWA
TCI Wealth Advisors
Tucson,
Arizona
|
-$201 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
RJA
1
Raymond James & Associates
St Petersburg,
Florida
| $1.1M | +$784K | +389,353 | New |
|
|
WAM
2
Wolverine Asset Management
Chicago,
Illinois
| $478K | +$314K | +155,673 | +1,155% |
|
|
ICM
3
Ionic Capital Management
New York
| $218K | – | – | – |
|
|
LCS
4
Levin Capital Strategies
New York
| $212K | -$578K | -287,000 | -79% |
|
|
WAM
5
Warberg Asset Management
Winnetka,
Illinois
| $37K | +$26.7K | +13,235 | New |
|
|
6
UBS Group
Zurich,
Switzerland
| $5K | +$3.6K | +1,785 | New |
|
|
TWA
7
TCI Wealth Advisors
Tucson,
Arizona
| $3K | -$201 | -100 | -8% |
|
8
Bank of America
Charlotte,
North Carolina
| $3K | – | – | – |
|
9
Morgan Stanley
New York
| $1K | – | – | – |
|
PAVMZ Hedge Fund Activity: Q1 2021 in Review
9 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in PAVmed Inc. Series Z Warrant (PAVMZ) for Q1 2021, worth a combined $2.06M — up 286% from $533K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new PAVMZ positions and 0 closed out — a net gain of 3 holders — while 1 added to existing stakes and 2 trimmed.
The largest buyer was Raymond James & Associates, opening a new position worth an estimated $784K. The largest seller was Levin Capital Strategies, cutting an estimated $578K.
- 9 institutional investors held PAVmed Inc. Series Z Warrant (PAVMZ) as of Q1 2021, up from 6 in Q4 2020.
- Funds reported $2.06M of PAVmed Inc. Series Z Warrant stock for Q1 2021, up 286% quarter-over-quarter.
- 3 funds opened new PAVmed Inc. Series Z Warrant positions in Q1 2021 and 0 closed out, a net change of +3 holders.
- The largest PAVmed Inc. Series Z Warrant buyer in Q1 2021 was Raymond James & Associates, an estimated $784K added.
- The largest PAVmed Inc. Series Z Warrant seller in Q1 2021 was Levin Capital Strategies, an estimated $578K sold.
Based on aggregated 13F filings for Q1 2021.